A Non-Hallucinogenic LSD Analogue With Therapeutic Potential in Mood Disorders

被引：0
|
作者：
Lewis, Vern [1 ]
Arsenault, Emily [1 ]
Bautista-Carro, Mario Alberto [1 ]
Taghavi-Abkuh, Fatimeh-Frouh [1 ]
El Sayegh, Fatema [1 ]
Valles, Argel Aguilar [1 ]
机构：
[1] Carleton Univ, Ottawa, ON, Canada
来源：
BIOLOGICAL PSYCHIATRY | 2023年 / 93卷 / 09期
关键词：
Serotonergic Psychedelics; Major depression disorder; Chronic Variable Stress; 2-Bromolysergic acid diethylamide;
D O I：
暂无
中图分类号：
Q189 [神经科学];
学科分类号：
071006 ;
摘要：
45
引用
收藏
页码：S112 / S112
页数：1
相关论文
共 50 条
  • [31] Cannabinoids in the therapeutic management of mood disorders
    Vasile, Daniel
    Vasiliu, Octavian
    Mangalagiu, Andrei Gabriel
    Petrescu, Bogdan Mircea
    Candea, Cristian Alexandru
    Tudor, Corina
    Bratu-Bizic, Roxana Elena
    Fainarea, Andreea Filareta
    Patrascu, Mihaela Cristina
    BIPOLAR DISORDERS, 2023, 25 : 83 - 83
  • [32] New Therapeutic Strategy for Mood Disorders
    Crupi, R.
    Marino, A.
    Cuzzocrea, S.
    CURRENT MEDICINAL CHEMISTRY, 2011, 18 (28) : 4284 - 4298
  • [33] New Therapeutic Targets for Mood Disorders
    Machado-Vieira, Rodrigo
    Salvadore, Giacomo
    DiazGranados, Nancy
    Ibrahim, Lobna
    Latov, David
    Wheeler-Castillo, Cristina
    Baumann, Jacqueline
    Henter, Ioline D.
    Zarate, Carlos A., Jr.
    THESCIENTIFICWORLDJOURNAL, 2010, 10 : 713 - 726
  • [34] LSD 1 is a Potential Therapeutic Target in Medulloblastoma
    Pajtler, K.
    Thor, T.
    Oles, L.
    Baumann, M.
    Heukamp, L. C.
    Buettner, R.
    Kirjel, J.
    Schramm, A.
    Eggert, A.
    Schulte, J.
    KLINISCHE PADIATRIE, 2009, 221 (03): : 203 - 204
  • [35] Prophylactic effects of arketamine, but not hallucinogenic psychedelic DOI nor non-hallucinogenic psychedelic analog lisuride, in lipopolysaccharide-treated mice and mice exposed to chronic restrain stress
    Liu, Guilin
    Ma, Li
    Qu, Youge
    Wan, Xiayun
    Xu, Dan
    Zhao, Mingming
    Murayama, Rumi
    Hashimoto, Kenji
    PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR, 2023, 233
  • [36] Sleep, mood disorders, and the ketogenic diet: potential therapeutic targets for bipolar disorder and schizophrenia
    Choi, Jinyoung
    Kang, Jiseung
    Kim, Tae
    Nehs, Christa J.
    FRONTIERS IN PSYCHIATRY, 2024, 15
  • [37] Inflammatory Mediators in Mood Disorders: Therapeutic Opportunities
    Pfau, Madeline L.
    Menard, Caroline
    Russo, Scott J.
    ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY, VOL 58, 2018, 58 : 411 - 428
  • [38] New Therapeutic Options for Anxiety and Mood Disorders
    Nardi, Antonio Egidio
    Machado, Sergio
    CNS & NEUROLOGICAL DISORDERS-DRUG TARGETS, 2014, 13 (06) : 927 - 929
  • [39] Allopregnanolone in mood disorders: Mechanism and therapeutic development
    Chen, Shiyi
    Gao, Lijuan
    Li, Xiaoyu
    Ye, Yiping
    PHARMACOLOGICAL RESEARCH, 2021, 169
  • [40] Nicotine as therapeutic agent in treatment of mood disorders
    Tsopelas, C.
    Petros, N.
    Maria, D.
    Dimitris, P.
    Angelica, G. G.
    Dimitra, K.
    Charalampos, T.
    EUROPEAN PSYCHIATRY, 2016, 33 : S552 - S552
12345